| 영문 | advanced cancer | 한글 | 진행암 |
|---|---|---|---|
| 설명 | 조기암에 대한 말로 암의 경과가 진행된 것을 말한다. |
||
| 영문 | lung cancer | 한글 | 폐암 |
|---|---|---|---|
| 설명 | 허파에 생기는 악성종양이다. 가장 예후가 나쁜 종양중의 하나로써 조기발견이 어렵고 증세 또한 늦게 나타나서, 그 종양의 종류에 따라 다르나 치료후에도 대개 8%만이 5년 생존이 가능한 악성종양이다. 유발인자로는 대표적으로 담배가 알려져 있으며, 유전적인 요소도 어느 정도 기여하는 것으로 알려져 있다. |
||
| 영문 | cancer chemotherapy | 한글 | 항암화학요법 |
|---|---|---|---|
| 설명 | 화학적 물질을 이용하여 암을 치료하는 것을 말한다. 이때 사용되는 물질을 항암제라고 한다. 이상적인 항암제는 정상적인 세포에는 이상이 없고 단지 암세포에만 치명적인 효과를 나타내어야 한다. 이렇게 하려면 암세포만의 특이한 특성을 이해하고 그곳에만 작용하는 약물을 개발하여야 한다. 최근 대부분의 항암제는 암세포가 정상 세포에 비하여 월등히 증식을 빨리한다는 특성을 이용하고 있다. 증식이 빠르다는 것은 유전정보를 가지고 있는 DNA의 복제가 빠르다는 것을 의미한다. 만약 DNA의 복제를 방해한다면 증식이 아주 빠른 암세포에게는 치명적이지만 영원히 증식을 하지 않는(DNA의 복제가 거의 필요없는)신경세포나 증식이 암세포에 비해서 아주 느린 정상세포에서는 거의 영향을 주지 못한다. 하지만 신체에서도 정상적으로 증식이 암세포와 비슷한 수준으로 일어나는 세포가 있는데 그것은 머리카락을 만드는 모낭세포와 소화관의 점막을 이루는 세포와 혈액의 세포를 만드는 골수 세포이다. 그러므로 항암제를 사용할 경우 이런 세포가 암세포와 마찬가지로 치명적인 영향을 입을 것은 당연하다(그래서 항암제 치료시엔 머리가 빠지고 소화불량이 잘온다). |
||
| ATS | Achard-Thiers syndrome; acid test solution; alpha-D-tocopherol acid succinate; American Thoracic Soc... |
|---|---|
| AAO | American Academy of Osteopathy; American Academy of Ophthalmology; American Academy of Optometry; Am... |
| ACA | abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino... |
| AOA | American Osteopathic Association; Administration on Aging; Alpha Omega Alpha Honor Society; American... |
| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| south american blastomycosis | A chronic fungal infection caused by Paracoccidioides brasiliensis, characterised by primary pulmonary lesions with dissemination to many visceral organs. Common findings include ulcerative granuloma lesions to the buccal mucosa (inner lining of the cheek) and nasal mucosa that extend to the surrounding skin. Generalised lymphangitis is also typical. More commonly seen in South America and the tropics. (27 Sep 1997) |
|---|---|
| South American trypanosomiasis | Trypanosomiasis caused by Trypanosoma (or Schizotrypanum) cruzi and transmitted by certain species of reduviid (triatomine) bugs. In its acute form, it is seen most frequently in young children, with swelling of the skin at the site of entry, most often the face, and regional lymph node enlargement; in its chronic form it can assume several aspects, commonly cardiomyopathy, but megacolon and megaesophagus also occur; natural reservoirs include dogs, armadillos, rodents, and other domestic, domiciliated, and wild mammals. Synonym: Chagas' disease, Chagas-Cruz disease, Cruz trypanosomiasis. (05 Mar 2000) |
| North American blastomycosis | A fungal infection caused by Blastomyces dermatitidis. This rare fungal infection may produce inflammatory lesion of the skin or lungs or present as a disseminated disease to the skin, lungs, bones, liver, spleen and central nervous system. Uncommon unless patient is immunocompromised (AIDS). (27 Sep 1997) |
| indians, central american | An ethnic group belonging to the mongoloid racial stock in central america. This does not include mexican indians. (12 Dec 1998) |
| indians, north american | An ethnic group belonging to the mongoloid racial stock in north america. (12 Dec 1998) |
| indians, south american | An ethnic group belonging to the mongoloid racial stock in south america. (12 Dec 1998) |
| oil of American wormseed | Volatile oil from the fresh above ground part of the flower, American wormseed, Chenopodium ambrosioides, or C. Anthelminticum. Used as an anthelmintic. Synonym: oil of American wormseed. (05 Mar 2000) |
| French-American-British classification | <haematology> The classification of acute myeloid leukaemia on the basis of bone marrow and peripheral blood features. M0: Acute myeloid leukaemia with minimal evidence of myeloid differentiation. M1: Acute myeloblastic leukaemia. M2: Acute myeloblastic leukaemia with differentiation. M3: Acute promyelocytic leukaemia. M4: Acute myelomonocytic leukaemia. M5: Acute monocytic leukaemia. M6: Acute erythroleukaemia. M7: Acute megakaryocytic leukaemia. Acronym: FAB (07 Apr 1998) |
| bladder cancer | The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour. (12 Dec 1998) |
| bladder cancer risks | Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers. (12 Dec 1998) |
| bone cancer | <oncology> A general term to imply malignant tumour growth in bone. (27 Sep 1997) |
| bovine cancer eye | A malignant squamous cell carcinoma of cattle, especially the Hereford breed, that originates in the conjunctival mucous membranes or the surrounding skin; it occurs principally in range cattle having unpigmented skin around the eye and living in regions of intense sunlight. (05 Mar 2000) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| breast cancer | <oncology> The uncontrolled growth of malignant breast tissue. Breast cancer is currently the most common cancer in women and the leading cause of cancer-related death in the 15-54 age group. Strong risk factors include a prior history for breast cancer or a positive family history for breast cancer. Early detection is possible through the use of monthly breast self-examination, annual clinical exams and mammography. WWW: cancerNET document for patients WWW: cancerNET document for clinicians (05 Jan 1998) |
| breast cancer susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |